“Harnessing Immune Checkpoint Inhibitors Against Gastric Cancer: Charting the Course to Expanded Therapeutic Benefit”. Biomedical Research and Therapy, vol. 11, no. 4, Apr. 2024, pp. 6305-2, https://doi.org/10.15419/bmrat.v11i4.877.